RxDoctor Payments DataLook up a doctor →

Amy Brettman, PA

Physician Assistant · Shawnee, KSNPI 1164824744

Payments from drug & device makers

$13,998in general payments, 2019–2025

Across 766 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Takeda Pharmaceuticals U.S.A., Inc.$2K
  • Johnson & Johnson$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$956
  • Pfizer$653
  • Lilly USA, LLC$589
  • plus $6K from 33 others

What the payments were for

  • Food & beverage$13,84299%
  • Education$1571%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,998 in reported general payments places this provider in the 95th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$15,506
Medicare patients
165
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide65$45,537
Mesalamine34$22,319
TrulancePlecanatide22$17,284
Dexlansoprazole DrDexlansoprazole38$9,679
Colestipol Hcl67$5,377
Famotidine160$3,839
Pantoprazole Sodium287$3,288
Mesalamine ErMesalamine20$3,285
Omeprazole260$3,219
Dicyclomine Hcl61$1,603
ErythromycinErythromycin Base11$1,498
Budesonide DrBudesonide14$1,178
Sucralfate33$1,131
Lansoprazole26$1,121
Lactated RingersRinger's Solution,lactated14$538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$2,545$45,53765 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$956$17,28422 claims
SandozLansoprazole$43$1,12126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Shawnee

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →